GLS and lung carcinoma: Sayin and LeBoeuf et al. demonstrated that inhibiting GLS1 in KEAP1 mutant lung cancer cells reduces cellular glutamate pools which diminishes its exchange with extracellular cysteine required for GSH biosynthesis [105].